This company has been marked as potentially delisted and may not be actively trading. Sun BioPharma (SNBP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SNBP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sun Pharma Q1 preview: High domestic, global specialty biz growth to boost revenueJuly 31 at 2:55 AM | msn.comIndia's Sun Pharma posts bigger adjusted profit on demand for rare disease drugsMay 23, 2025 | msn.comIndia's Sun Pharma posts quarterly profit rise on strong demand for rare disease drugsMay 22, 2025 | msn.comSun Pharma's Checkpoint Bid Seen As A Strategic Win By MacquarieMay 20, 2025 | msn.comIndia's Sun Pharma to acquire Checkpoint Therapeutics for $355 millionMarch 10, 2025 | msn.comSun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip ShanghviMarch 3, 2025 | msn.comSun Pharma share price plunges 5% after US ruling on Leqselvi launch - Here's what JPMorgan, UBS sayNovember 5, 2024 | msn.comSun Pharma shares in focus as US court blocks Leqselvi launchNovember 4, 2024 | msn.comSun Pharma shares in spotlight after Q2 profit rises 28% YoY to Rs 3,040 crore. Should you invest?October 29, 2024 | msn.comIndia's Sun Pharma beats Q2 profit view on higher demand for specialty drugsOctober 28, 2024 | msn.comSun Pharma Q2 Results Preview: PAT may rise 25% YoY; healthy revenue growth seenOctober 27, 2024 | msn.comSun Pharmaceutical Industries falls Tuesday, still outperforms marketOctober 22, 2024 | marketwatch.comSun Pharmaceutical Industries rises Monday, still underperforms marketOctober 14, 2024 | marketwatch.comSun Pharmaceutical Industries rises Tuesday, still underperforms marketOctober 8, 2024 | marketwatch.comSun Pharma Shares Rally In Green: Company Stocks Soar Despite Lab Test FiascoSeptember 27, 2024 | msn.comGlenmark, JB Pharma, Sun, Zydus Lifescience drive pharma market growth in AugustSeptember 20, 2024 | msn.comSun Pharmaceutical Industries rises Thursday, still underperforms marketSeptember 12, 2024 | marketwatch.comSun Pharmaceutical Industries underperforms Tuesday when compared to competitors despite daily gainsSeptember 11, 2024 | marketwatch.comSun Pharmaceutical Industries falls Friday, still outperforms marketSeptember 6, 2024 | marketwatch.comSun Pharmaceutical Industries underperforms Wednesday when compared to competitors despite daily gainsAugust 28, 2024 | marketwatch.comSun Pharma launches novel therapy for skin disorders in IndiaAugust 23, 2024 | msn.comSun Pharma, Lupin, Cipla others: 4 key reason why Pharma index has risen 34% ytd, outperforming benchmark Nifty-50 indexAugust 23, 2024 | msn.comSun Pharmaceutical Industries falls Thursday, underperforms marketAugust 22, 2024 | marketwatch.comPharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.August 21, 2024 | markets.businessinsider.comSun Pharmaceutical Industries falls Wednesday, underperforms marketAugust 21, 2024 | marketwatch.comSun Pharmaceutical Industries rises Friday, still underperforms marketAugust 16, 2024 | marketwatch.comSun Pharmaceutical Industries rises Wednesday, still underperforms marketAugust 14, 2024 | marketwatch.comIndian pharmaceutical billionaire brings 4,500 employees to visit VietnamAugust 14, 2024 | msn.comSun Pharmaceutical Industries falls Monday, underperforms marketAugust 12, 2024 | marketwatch.comSun Pharmaceutical Industries underperforms Friday when compared to competitorsAugust 9, 2024 | marketwatch.comSun Pharma Shares Recover From Lows As Brokerages Scratch Their Heads Over Q1 ResultsAugust 2, 2024 | msn.comSun Pharmaceutical Industries Q1 Results Live : profit rise by 40.2% YOYAugust 2, 2024 | msn.comWhat Wall Street expects from Sun Pharmaceutical's earningsJuly 31, 2024 | markets.businessinsider.comSun Pharma gets USFDA nod for its formulation to treat Severe Alopecia AreataJuly 26, 2024 | msn.comSun Pharmaceutical Industries rises Friday, outperforms marketJuly 26, 2024 | marketwatch.comSun Pharma gets US FDA nod for its specialty drug against baldnessJuly 26, 2024 | msn.comSC upholds NPPA's Rs 4.6 crore penalty on Sun PharmaJuly 19, 2024 | msn.comBuy Sun Pharmaceutical Industries; target of Rs 1710: Prabhudas LilladherMay 29, 2024 | msn.comAs four-year doping ban ends, China's Sun eyes return to poolMay 28, 2024 | reuters.comBuy Sun Pharmaceutical Industries; target of Rs 1,827: KR ChokseyMay 28, 2024 | msn.comSun Pharma shares tumble 5% but brokerages raise target up to Rs 1,785. Should you buy, sell or hold?May 23, 2024 | msn.comSun Pharmaceutical Industries Q4 Results Live : profit rise by 33.77% YOYMay 23, 2024 | msn.comSun Pharma Shares In The Red After Giving Low Guidance For Coming YearMay 23, 2024 | msn.comSun Pharma Share Price Target 2024: Rs 5 DIVIDEND in Q4 results; BUY, SELL or HOLD?May 23, 2024 | msn.comSun Pharma Q4FY24 PAT grows 34% to Rs 2,655 cr; Rs 5 per share dividend declaredMay 22, 2024 | msn.comSun Pharma Q4 net profit up by 34%May 22, 2024 | msn.comSun Pharma Q4 FY 2024: 500% DIVIDEND announced, stock up 1.5 per cent as company announces quarterly earningsMay 22, 2024 | msn.comIndia's Sun Pharma beats Q4 profit view on strong US, domestic salesMay 22, 2024 | reuters.comIndia's Sun Pharma beats Q4 profit estimatesMay 22, 2024 | reuters.comSun Pharma Q4 Results 2024 Date and Time: Dividend news, quarterly earnings preview, expectationsMay 21, 2024 | msn.com Get Sun BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SNBP and its competitors with MarketBeat's FREE daily newsletter. Email Address SNBP Media Mentions By Week SNBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNBP News Sentiment▼0.000.46▲Average Medical News Sentiment SNBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNBP Articles This Week▼10▲SNBP Articles Average Week Get Sun BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SNBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IBIO News AEON News CPHI News NRBO News SPRB News MTNB News NBY News PTN News CANF News VCNX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNBP) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sun BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sun BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
